Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biochemical Pharmacology|January 30, 2017
Inhibition of 11β-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazoleKatharina R Beck, Murielle Bächler, Anna Vuorinen, et al.
Bioorganic & Medicinal Chemistry|April 2, 2019
Profiling withanolide A for therapeutic targets in neurodegenerative diseasesErika A Crane, Wolfgang Heydenreuter, Katharina R Beck, et al.
Biochemical Pharmacology|December 30, 2019
Profiling of anabolic androgenic steroids and selective androgen receptor modulators for interference with adrenal steroidogenesisMelanie Patt, Katharina R Beck, Tobias Di Marco, et al.
Nature Communications|September 5, 2025
Gut microbial production of imidazole propionate drives Parkinson's pathologiesHyunji Park, Jiwon Cheon, Hyojung Kim, et al.
Molecular Metabolism|March 31, 2021
Carbonyl reductase 1 amplifies glucocorticoid action in adipose tissue and impairs glucose tolerance in lean miceRachel M B Bell, Elisa Villalobos, Mark Nixon, et al.
Nature Communications|June 26, 2026
Gut bacterial metabolite imidazole propionate potentiates Alzheimer's disease pathologyVaibhav Vemuganti, Jea Woo Kang, Qijun Zhang, et al.
Scientific Reports|September 8, 2017
Carbonyl reductase 1 catalyzes 20β-reduction of glucocorticoids, modulating receptor activation and metabolic complications of obesityRuth A Morgan, Katharina R Beck, Mark Nixon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 27, 2025
Gut Microbial Metabolite Imidazole Propionate Impairs Endothelial Cell Function and Promotes the Development of AtherosclerosisVanasa Nageswaran, Alba Carreras, Leander Reinshagen, et al.
European Heart Journal|August 30, 2025
Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery diseaseFlorian A Wenzl, Peizhi Wang, Florian Kahles, et al.
Nature|July 16, 2025
Imidazole propionate is a driver and therapeutic target in atherosclerosisAnnalaura Mastrangelo, Iñaki Robles-Vera, Diego Mañanes, et al.
Pageof 2